These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30877936)

  • 1. Total synthesis of scutellarin and apigenin 7-O-β-d-glucuronide.
    Liu X; Wen GE; Liu JC; Liao JX; Sun JS
    Carbohydr Res; 2019 Mar; 475():69-73. PubMed ID: 30877936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new and efficient synthesis of 6-O-methylscutellarein, the major metabolite of the natural medicine scutellarin.
    Zhang W; Dong ZX; Gu T; Li NG; Zhang PX; Wu WY; Yu SP; Tang YP; Yang JP; Shi ZH
    Molecules; 2015 Jun; 20(6):10184-91. PubMed ID: 26042857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity.
    Yang B; Zhao YL; Yang X; Liao XL; Yang J; Zhang JH; Gao CZ
    Carbohydr Polym; 2013 Feb; 92(2):1308-14. PubMed ID: 23399159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin.
    Dong ZX; Li NG; Zhang PX; Gu T; Wu WY; Shi ZH
    Molecules; 2016 Feb; 21(3):263. PubMed ID: 26927039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first total synthesis of 7-O-beta-D-glucopyranosyl-4'-O-alpha-L-rhamnopyranosyl apigenin via a hexanoyl ester-based protection strategy.
    Gao Q; Lian G; Lin F
    Carbohydr Res; 2009 Mar; 344(4):511-5. PubMed ID: 19187930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Effect of Glucuronidation of a Pyrogallol-Type Phytophenol Antioxidant: A Comparison between Scutellarein and Scutellarin.
    Liu Q; Li X; Ouyang X; Chen D
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of glucose-containing scutellarein derivatives as neuroprotective agents based on metabolic mechanism of scutellarin in vivo.
    Li NG; Shen MZ; Wang ZJ; Tang YP; Shi ZH; Fu YF; Shi QP; Tang H; Duan JA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):102-6. PubMed ID: 23177255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Scutellarein Derivatives with a Long Aliphatic Chain and Their Biological Evaluation against Human Cancer Cells.
    Ni G; Tang Y; Li M; He Y; Rao G
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29389889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury.
    Lu J; Cheng C; Zhao X; Liu Q; Yang P; Wang Y; Luo G
    Eur J Med Chem; 2010 May; 45(5):1731-8. PubMed ID: 20117861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two major urinary metabolites of scutellarin in rats.
    Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
    Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficient total synthesis of bis-glycosyl apigenin from naringenin: a greener way.
    Chen J; Huang W; Lian G; Lin F
    Carbohydr Res; 2009 Nov; 344(16):2245-9. PubMed ID: 19729151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates.
    Zhou Q; Jiang X; Li K; Fan X
    Pharmazie; 2006 Aug; 61(8):660-3. PubMed ID: 16964704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative.
    Gu T; Zhong Y; Lu YT; Sun Y; Dong ZX; Wu WY; Shi ZH; Li NG; Xue X; Fang F; Li HM; Tang YP
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28635646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation.
    Han T; Li J; Xue J; Li H; Xu F; Cheng K; Li D; Li Z; Gao M; Hua H
    Eur J Med Chem; 2017 Jul; 135():270-281. PubMed ID: 28458133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new and practical synthetic method for the synthesis of 6-O-methyl-scutellarein: one metabolite of scutellarin in vivo.
    Lin H; Zhang W; Dong ZX; Gu T; Li NG; Shi ZH; Kai J; Qu C; Shang GX; Tang YP; Fang F; Li HM; Yang JP; Duan JA
    Int J Mol Sci; 2015 Apr; 16(4):7587-94. PubMed ID: 25854429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic investigation toward apigenin 5-O-glycoside camellianin B as well as the chemical structure revision.
    Hu Y; Tu YH; Liu DY; Liao JX; Sun JS
    Org Biomol Chem; 2016 Jun; 14(21):4842-7. PubMed ID: 27145917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First synthesis of saponarin, 6-C- and 7-O-di-β-D-glucosylapigenin.
    Misawa K; Takahashi Y; Sato S
    Chem Pharm Bull (Tokyo); 2013; 61(7):776-80. PubMed ID: 23812402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
    Huang JM; Weng WY; Huang XB; Ji YH; Chen E
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.
    Chen X; Cui L; Duan X; Ma B; Zhong D
    Drug Metab Dispos; 2006 Aug; 34(8):1345-52. PubMed ID: 16714374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2.
    You L; Zhu H; Wang C; Wang F; Li Y; Li Y; Wang Y; He B
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5404-5408. PubMed ID: 29157862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.